Nauras Shuker

A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype‐Based With Body‐Weight‐Based Tacrolimus Dosing After Living Donor Kidney Transplantation

Nauras Shuker, Rachida Bouamar, Ron H. N. van Schaik et al. · American Journal of Transplantation · 2015 · 168 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized-Controlled Clinical Trials

Rachida Bouamar, Nauras Shuker, Dennis A. Hesselink et al. · American Journal of Transplantation · 2013 · 156 citations

Medicine, Nephrology, Pharmacokinetics +17

A high intrapatient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantation

Nauras Shuker, Lamis Shuker, Joost van Rosmalen et al. · Transplant International · 2016 · 149 citations

Pharmacy, Nephrology, Pharmacokinetics +17

Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting Dose

Louise M. Andrews, Brenda C. M. de Winter, Jiangtao Tang et al. · Transplantation Direct · 2017 · 40 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Highly sensitive and rapid determination of tacrolimus in peripheral blood mononuclear cells by liquid chromatography–tandem mass spectrometry

Soma Bahmany, L. Elly A. de Wit, Dennis A. Hesselink et al. · Biomedical Chromatography · 2018 · 33 citations · Full text

Pharmacy, Immunology, Pharmacology +14